메뉴 건너뛰기




Volumn 17, Issue 2, 2008, Pages 293-297

On survival consumption costs - A reply to Nyman

Author keywords

[No Author keywords available]

Indexed keywords

BUDGET; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE UTILIZATION; HUMAN; NOTE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SOCIAL WELFARE; SURVIVAL;

EID: 39449107485     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1290     Document Type: Note
Times cited : (19)

References (12)
  • 1
    • 0032733741 scopus 로고    scopus 로고
    • Life-cycle preferences over consumption and health: When is cost-effectiveness analysis equivalent to cost-benefit analysis?
    • Bleichrodt H, Quiggin J. 1999. Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis? Journal of Health Economics 18: 681-708.
    • (1999) Journal of Health Economics , vol.18 , pp. 681-708
    • Bleichrodt, H.1    Quiggin, J.2
  • 2
    • 0036172882 scopus 로고    scopus 로고
    • QALYs, standard gambles, and the expected budget constraint
    • Blomqvist A. 2002. QALYs, standard gambles, and the expected budget constraint. Journal of Health Economics 21: 181-195.
    • (2002) Journal of Health Economics , vol.21 , pp. 181-195
    • Blomqvist, A.1
  • 3
    • 33644792202 scopus 로고    scopus 로고
    • Consumption costs and earnings during added years of life - a reply to Nyman
    • Gandjour A. 2006. Consumption costs and earnings during added years of life - a reply to Nyman. Health Economics 15: 319-322.
    • (2006) Health Economics , vol.15 , pp. 319-322
    • Gandjour, A.1
  • 5
    • 0036772508 scopus 로고    scopus 로고
    • QALYs versus WTP
    • Hammitt J. 2002. QALYs versus WTP. Risk Analysis 22: 985-1001.
    • (2002) Risk Analysis , vol.22 , pp. 985-1001
    • Hammitt, J.1
  • 6
    • 2142845765 scopus 로고    scopus 로고
    • How much is a QALY worth? Admissible utility functions for health and wealth
    • Harvard University: Boston
    • Hammitt J. 2002. How much is a QALY worth? Admissible utility functions for health and wealth. In Center for Risk Analysis. Harvard University: Boston.
    • (2002) Center for Risk Analysis
    • Hammitt, J.1
  • 7
    • 0035051726 scopus 로고    scopus 로고
    • On individual preferences and aggregation in economic evaluation in healthcare
    • Liljas B, Lindgren B. 2007. On individual preferences and aggregation in economic evaluation in healthcare. Pharmacoeconomics 19(4): 323-335.
    • (2007) Pharmacoeconomics , vol.19 , Issue.4 , pp. 323-335
    • Liljas, B.1    Lindgren, B.2
  • 8
    • 0030915977 scopus 로고    scopus 로고
    • Accounting for future costs in medical cost-effectiveness analysis
    • Meltzer D. 1997. Accounting for future costs in medical cost-effectiveness analysis. Journal of Health Economics 16: 249-255.
    • (1997) Journal of Health Economics , vol.16 , pp. 249-255
    • Meltzer, D.1
  • 9
    • 2442702844 scopus 로고    scopus 로고
    • Should the consumption of survivors be included as a cost in cost-utility analysis?
    • Nyman JA. 2004. Should the consumption of survivors be included as a cost in cost-utility analysis? Health Economics 13: 417-427.
    • (2004) Health Economics , vol.13 , pp. 417-427
    • Nyman, J.A.1
  • 10
    • 33644792202 scopus 로고    scopus 로고
    • More on survival consumption costs in cost-utility analysis?
    • Nyman JA. 2006. More on survival consumption costs in cost-utility analysis? Health Economics 15: 319-322.
    • (2006) Health Economics , vol.15 , pp. 319-322
    • Nyman, J.A.1
  • 12
    • 33644812437 scopus 로고    scopus 로고
    • In defence of societal sovereignty: A comment on Nyman 'the inclusion of survivor consumption in CUA'
    • Richardson J, Olsen J. 2006. In defence of societal sovereignty: a comment on Nyman 'the inclusion of survivor consumption in CUA'. Health Economics 15: 319-322.
    • (2006) Health Economics , vol.15 , pp. 319-322
    • Richardson, J.1    Olsen, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.